Greenlee H B, Stanley M M, Reinhardt G F
Arch Surg. 1981 May;116(5):518-24. doi: 10.1001/archsurg.1981.01380170016003.
Peritoneovenous shunts (LeVeen) were placed in 52 patients with intractable ascites due to alcoholic cirrhosis between March 1975 and June 1978. The ascites was defined as intractable if it persisted despite at least six weeks of in-hospital medical management. Only 4.5% of such patients seen during this interval met this criterion by failing to respond to intensive drug and diet therapy. Eight (15%) died five to 60 days postoperatively; six of these did not undergo diuresis. Hepatic encephalopathy and sepsis were important contributing factors. There were 21 late deaths (mean survival, 16 months), primarily related to complications characteristic of this group of cirrhotics: upper gastrointestinal hemorrhage and infection. Twenty-three patients were alive by June 25, 1980, with mean survival of 46 months. Four patients operated on five or more years ago survive without ascites. An accurately placed LeVeen shunt dramatically relieves intractable ascites with improvement in renal function, nutrition, and general health. The operation enables at least partial rehabilitation so that ambulatory care becomes feasible for many of these chronically and seriously disabled patients.
1975年3月至1978年6月期间,为52例因酒精性肝硬化导致顽固性腹水的患者置入了腹腔静脉分流管(LeVeen分流管)。若患者在住院接受至少六周的内科治疗后腹水仍持续存在,则定义为顽固性腹水。在此期间就诊的此类患者中,只有4.5%因对强化药物和饮食治疗无反应而符合这一标准。8例(15%)患者术后5至60天死亡;其中6例未出现利尿。肝性脑病和败血症是重要的促成因素。有21例患者晚期死亡(平均生存期16个月),主要与这类肝硬化患者的典型并发症有关:上消化道出血和感染。截至1980年6月25日,有23例患者存活,平均生存期46个月。4例在五年或更早之前接受手术的患者存活且无腹水。准确置入的LeVeen分流管可显著缓解顽固性腹水,同时改善肾功能、营养状况和总体健康。该手术至少能使部分患者康复,从而使许多长期严重残疾的患者能够接受门诊治疗。